Maisa Kasanga

Dr. Maisa Kasanga


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
MKMaisa Kasanga
Maisa Kasanga
GKGeoffrey Kwenda
Geoffrey Kwenda
JWJian Wu
Jian Wu
MKMaika Kasanga
Maika Kasanga
MMMark John Mwiikisa
Mark John Mwiikisa
DCDuncan Mwelwa Chanda
Duncan Mwelwa Chanda
Antimicrobial resistance (AMR) is a public health problem threatening human, animal, and environmental safety. This study assessed the AMR profiles and risk factors associated with Escherichia coli in hospital and environmental settings in Lusaka, Zambia. This cross-sectional study was conducted from April 2022 to August 2022 using 980 samples collected from clinical and environmental settings. Antimicrobial susceptibility testing was conducted using BD PhoenixTM 100. The data were analysed using SPSS version 26.0. Of the 980 samples, 51% were from environmental sources. Overall, 64.5% of the samples tested positive for E. coli, of which 52.5% were from clinical sources. Additionally, 31.8% were ESBL, of which 70.1% were clinical isolates. Of the 632 isolates, 48.3% were MDR. Most clinical isolates were resistant to ampicillin (83.4%), sulfamethoxazole/trimethoprim (73.8%), and ciprofloxacin (65.7%) while all environmental isolates were resistant to sulfamethoxazole/trimethoprim (100%) and some were resistant to levofloxacin (30.6%). The drivers of MDR in the tested isolates included pus (AOR = 4.6, CI: 1.9–11.3), male sex (AOR = 2.1, CI: 1.2–3.9), and water (AOR = 2.6, CI: 1.2–5.8). This study found that E. coli isolates were resistant to common antibiotics used in humans. The presence of MDR isolates is a public health concern and calls for vigorous infection prevention measures and surveillance to reduce AMR and its burdens.

10 June 2020 in Pan African Medical Journal
Verified
Journal Article
Open access
MKMaisa Kasanga
Maisa Kasanga
SMSteward Mudenda
Steward Mudenda
TGTheodore Gondwe
Theodore Gondwe
MCMisheck Chileshe
Misheck Chileshe
BSBenjamin Solochi
Benjamin Solochi
JWJian Wu
Jian Wu
Coronavirus disease 2019 (COVID-19) is a novel respiratory tract disease that is caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 was first reported in Wuhan, China, and spread to other countries at a very rapid rate. Coronavirus disease 2019 has caused many negative impacts on healthcare and educational services. Due to an increase in COVID-19 cases and mortality, blood donation has been reported to reduce in many parts of the world. Zambia is among the countries that have recorded a sharp reduction in blood donations. It is therefore important that healthcare institutions put in place measures to promote the supply of blood and maintain blood transfusion services.

1 November 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
CCChikwanda Chileshe
Chikwanda Chileshe
FGFusya Goma
Fusya Goma
NMNtombi B. Mudenda
Ntombi B. Mudenda
Steward MudendaSteward Mudenda
Steward Mudenda
Taona SinyawaTaona Sinyawa
Taona Sinyawa
RCRoma Chilengi
Roma Chilengi
Background: Zambia, like many low- and middle-income countries, faces a growing burden of antimicrobial resistance (AMR), driven by the misuse of antimicrobials in both human and animal health, a limited diagnostic capacity, and weak regulatory enforcement. To address this challenge, Standard Treatment Guidelines (STGs) were developed for the veterinary sector, which represents a major milestone in the country’s AMR containment strategy. STGs are evidence-based protocols that guide veterinary professionals in consistently and appropriately diagnosing and treating animal diseases. They promote the rational use of veterinary medicines, and can mitigate AMR and improve animal health outcomes. By translating the best evidence into best practices, STGs also provide a practical foundation for antimicrobial stewardship (AMS) programs. Until 2023, Zambia lacked nationally adopted STGs for the veterinary sector. The introduction and standardization of these guidelines are expected to promote prudent antimicrobial use and raise the standard of care delivered to animal patients across the country. Objective: The aim of this paper is to provide a practical reference for future revisions of STGs and outline the successful methodology used to create STGs in the Zambian animal sector. Methods: A situational analysis was conducted to identify priority animal health conditions and existing treatment gaps within the veterinary sector. A multidisciplinary expert committee was then formed, comprising veterinarians, veterinary paraprofessionals, academics, regulatory authorities, and private sector stakeholders, to lead the development of the STGs. The process was guided by the WHO methodology for developing treatment guidelines, including a comprehensive review of the clinical evidence, local disease patterns, antimicrobial resistance data, and existing treatment practices. Draft STGs were developed with clearly defined, species-specific treatment protocols tailored to the Zambian context. For the validation process, the AGREE II instrument was used to assess the quality, clarity, and applicability of the guidelines. Structured stakeholder consultations with practitioners, policy-makers, and technical experts were held to ensure that the guidelines were practical, evidence-based, and aligned with national priorities. The validated drafts were then disseminated and piloted in selected districts. Conclusions: The development of the species-specific STGs represents an essential turning point in the country’s efforts to promote responsible veterinary care and contain AMR. STGs have become a prominent key support in the delivery of quality animal care. Further, the guidelines will assist in the optimization of antimicrobial use in animal health in Zambia.

7 November 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
JCJoseph Chizimu
Joseph Chizimu
Steward MudendaSteward Mudenda
Steward Mudenda
VDVictor Daka
Victor Daka
WMWebrod Mufwambi
Webrod Mufwambi
ZMZoran Miyanda Muhimba
Zoran Miyanda Muhimba
RCRoma Chilengi
Roma Chilengi
Background/Objectives: Antimicrobial resistance (AMR) is a critical global health threat, with sub-Saharan Africa disproportionately affected. Antimicrobial stewardship (AMS) programs are essential in combating AMR; however, data on their implementation in resource-limited settings like Zambia remain scarce. This study assessed the post-implementation status of World Health Organization (WHO) AMS core elements in selected public hospitals in Zambia. Methods: A cross-sectional pre- and post-intervention survey was conducted in 11 public hospitals across Zambia’s 10 provinces. Baseline (pre-implementation) and 12-month follow-up (post-implementation) assessments were carried out using the WHO-adapted Periodic National and Healthcare Facility Assessment Tool. The six AMS core elements evaluated included leadership, accountability, AMS actions, education, monitoring, and feedback. Results: The average AMS program score increased from 59% at pre-implementation to 81% at post-implementation. Significant improvements were observed in education and training (+36%) and accountability (+31%). While leadership and monitoring also showed positive trends, gaps persisted in AMS actions (63%) and feedback/reporting mechanisms (68%). Drug and Therapeutics Committee (DTC) functionality improved by 23%, with 90% of facilities now holding regular DTC meetings. Implementation of AMS actions, such as ward rounds, rose from 0% to 73%. Challenges remained in clinical audit feedback, resource mobilization, and prescribing optimization. Variability across facilities highlighted differences in leadership, resources, and technical capacity. Conclusions: AMS implementation in Zambia improved substantially across key domains. However, sustained leadership, adequate financing, and continuous capacity-building are needed to address persistent gaps and ensure long-term success in mitigating AMR.

2 March 2020 in Research Square
Verified
Preprint
Open access
PDF file
WRWeicun Ren
Weicun Ren
XFXiaoli Fu
Xiaoli Fu
CTClifford Silver Tarimo
Clifford Silver Tarimo
MKMaisa Kasanga
Maisa Kasanga
YWYanqing Wang
Yanqing Wang
JWJian Wu
Jian Wu
Background Traditional medicine has long been used to address relatively common illness, and Chinese government has been continually increasing its investments on Public Traditional Chinese Medicine hospitals (PTHs) in recent years. Objectives This study aimed to assess the scales and structure of investments on PTHs in Henan Province, China, in order to analyze the contribution of Government Financial Investment (GFI) to the revenue growth of PTHs, as well as raising practical investment strategies for decision-makers. Methods This study was a panel data research, conducted in Henan Province, China. By collecting 143 PTHs’ operational data from 2005 to 2017, the authors computed data with Barrow Economic Growth Model (BEG), Stochastic Frontier Analysis (SFA) and Vector Autoregressive Model (VAR), respectively.Results The study observed that the contribution of GFI to PTHs’ revenue growth was positive (average MPG=2.84), which means the scale of GFI hadn’t reached an optimal level. The scales of GFI on Grade III, Grade II A, Grade II B PTHs need to be increased by -5.96%, 4.88% and 11.51% respectively in order to maximize the input-output efficiency. The third year after the investment year may be a more effective period for conducting an effect evaluation of GFI in Henan Province.Conclusions GFI on PTHs usually has a long-term impact on PTHs. Government needs to adjust its GFI policy to maximize the input-output efficiency.